News

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...
A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...
A cure for diabetes has been top of mind for many that live with the conditions under the term’s umbrella. But type 1 ...
The first diabetes and obesity pill that is similar to Ozempic — but in tablet form — may actually outperform the popular ...
A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...
Lower blood sugar and increased fat burning – without negatively affecting appetite or muscle mass. These are some of the ...
This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.
A drug commonly used to treat type 2 diabetes may reduce excess fluid in the brains of patients with hydrocephalus, which ...
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.